INSM Related FDA

Mar 27, 2013 01:11 PM Insmed (INSM) Recieves FDA Orphan Status for Arikace

Nov 13, 2012 08:06 AM Insmed (INSM) Commences CLEAR-108 Phase 3 in Europe, Canada

Aug 2, 2012 08:03 AM Insmed (INSM) Gets New Composition Matter U.S. Patent for ARIKACE

Jun 27, 2012 08:02 AM Insmed (NSM) Doses First Patient in ARIKACE Phase 2

May 7, 2012 08:02 AM Insmed (INSM) Says Clinical Hold on ARIKACE in CF Patients Lifted

Feb 10, 2012 08:05 AM Insmed (INSM) Commences ARIKACE Phase 2 in NTM Lung Disease Patients, Phase 3 in CF Patients w/ Pa

Jan 20, 2012 08:03 AM FDA Lifts Clinical Hold on Insmed (INSM) ARIKACE in NTM Patients; Continues CF Negotiations

Jan 20, 2012 08:01 AM Insmed (INSM) says FDA lifts clinical hold on arikace

Oct 14, 2011 08:10 AM FDA Continues Clinical Hold on Insmed (INSM) ARIKACE Phase 3; More Info Needed

Oct 10, 2011 08:11 AM FDA Clinical Hold Continues for Insmed's (INSM) ARIKACE

Aug 2, 2011 09:31 AM Insmed (INSM) Slammed as FDA Puts Clinical Hold on ARIKACE

Mar 3, 2011 08:24 AM Insmed's (INSM) ARIKACE Receives Positive Opinion from Pediatric Committee of EMA

Jun 25, 2009 08:12 AM Insmed (INSM) Announces That IPLEX Phase II Trial Did Not Meet A Statistically Significant Improvement

Dec 18, 2007 09:05 AM Insmed Inc (INSM) Granted Orphan Drug Designation for IPLEX

Jan 4, 2006 11:05 AM U. of Rochester Initiates Phase 2 Clinical Trial of INSM's iPlex

Dec 12, 2005 05:16 PM INSM Said FDA Approves Orphan Drug, IPLEX

Oct 25, 2005 02:18 PM FDA to Review Insmed's Complete Response to Approvable Letter for iPlex on 10/12

Sep 29, 2005 04:08 PM INSM Said iPlex Effective in Study

Sep 27, 2005 11:31 PM INSM Receives Approvable Letter for iPlex

Jun 17, 2005 09:13 AM TRCA to Withdraw Motion for a Preliminary Injunction Against Insmed

Jun 10, 2005 07:20 AM INSM: FDA Delays PDUFA Date for SomatoKine

May 31, 2005 04:10 PM INSM Reports Positive Results from Its Pivotal Clinical Trial of SomatoKine

Apr 26, 2005 08:43 AM INSM Initiates Phase II Trial With SomatoKine(R) in Type A Extreme Insulin Resistance

Apr 20, 2005 08:07 AM INSM Initiates Phase II HIV-Associated Lipodystrophy Trial

Apr 13, 2005 11:33 AM INSM Grants FDA Priority Review for SomatoKine

Mar 10, 2005 11:03 AM FDA Accepts for Review INSM's NDA for SomatoKine